Toxoplasmosis and allogeneic stem cell transplantation: can we do better?

Slavin, Monica A

doi:10.3109/10428194.2010.503822

Cited by 4 publications

(3 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The incidence of toxoplasmosis in allo-HCT recipients ranges from 6% in Europe to <0.5% in USA or Japan [12]. In one prospective study, 16% reactivated the infection over the first 6 months posttransplant and 6% developed disease [7].…”

Section: Discussionmentioning

confidence: 99%

Toxoplasmosis after allogeneic haematopoietic cell transplantation: experience using a PCR-guided pre-emptive approach

Aerts

Mercier

Beckers

et al. 2022

Clinical Microbiology and Infection

View full text Add to dashboard Cite

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

show abstract

Section: Discussionmentioning

confidence: 99%

Toxoplasmosis after allogeneic haematopoietic cell transplantation: experience using a PCR-guided pre-emptive approach

Aerts

Mercier

Beckers

et al. 2022

Clinical Microbiology and Infection

View full text Add to dashboard Cite

show abstract

“…On the basis of our experience and building on previous studies, recommendations from the American Society for Blood and Marrow Transplantation and a commentary by a renowned investigator, M.A. Slavin, we recommend the following [10,57]:…”

Section: Conclusion and Recommendationsmentioning

confidence: 94%

Toxoplasma prophylaxis in haematopoietic cell transplant recipients

Gajurel

Dhakal

Montoya

2015

Current Opinion in Infectious Diseases

133

View full text Add to dashboard Cite

show abstract

“…11,37,41 For patients who are T. gondii IgG positive, the use of trimethoprim/sulfamethoxazole for prophylaxis remains the drug of choice. Those who are seronegative should be informed about the risk of contracting toxoplasmosis and should avoid handling cat feces and avoid eating undercooked meat.…”

Section: Prophylactic Therapy For Toxoplasmosismentioning

confidence: 99%

Prophylaxis for Infections Following Allogeneic Hematopoietic Stem Cell Transplantation

Dukkipati

Velez²,

Yacoub³

et al. 2015

Infectious Diseases in Clinical Practice

View full text Add to dashboard Cite

The objectives of this article were to provide data on the current guidelines for the prophylactic therapy with the evidence-based approach in mind and to serve as a reference and guide for the health care providers who care for hematopoietic stem cell transplantation (HSCT) patients and a reference for the HSCT recipients and their family members. Prophylaxis for the various infections, which are commonly encountered in the HSCT patients, is discussed in this article.

show abstract

Toxoplasmosis and allogeneic stem cell transplantation: can we do better?

Cited by 4 publications

References 10 publications

Toxoplasmosis after allogeneic haematopoietic cell transplantation: experience using a PCR-guided pre-emptive approach

Toxoplasmosis after allogeneic haematopoietic cell transplantation: experience using a PCR-guided pre-emptive approach

Toxoplasma prophylaxis in haematopoietic cell transplant recipients

Prophylaxis for Infections Following Allogeneic Hematopoietic Stem Cell Transplantation

Contact Info

Product

Resources

About